Table 5. Genes significantly altered in brain samples from mice exhibiting clinical signs of neosporosis.
| Gene symbol | Description | Average of FPMK | FPKM Fold change | FDR | |
|---|---|---|---|---|---|
| No signs (n = 2) | Clinical signs (n = 2) | ||||
| Hoxb5 | homeobox B5 | 1.09 | 0.09 | 0.08 | 7.33.E-04 |
| Slc6a4 | solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 | 2.94 | 0.38 | 0.13 | 3.04.E-09 |
| BC037034 | cDNA sequence BC037034 | 10.04 | 1.44 | 0.14 | 9.05.E-03 |
| Tph2 | tryptophan hydroxylase 2 | 4.03 | 0.88 | 0.22 | 6.85.E-06 |
| Slc6a5 | solute carrier family 6 (neurotransmitter transporter, glycine), member 5 | 4.15 | 0.95 | 0.23 | 3.84.E-06 |
| Mab21l2 | mab-21-like 2 (C. elegans) | 3.26 | 1.08 | 0.33 | 2.41.E-02 |
| Fos | FBJ osteosarcoma oncogene | 33.97 | 12.06 | 0.36 | 5.30.E-03 |
| Ldlr | low density lipoprotein receptor | 7.42 | 2.89 | 0.39 | 9.05.E-03 |
(>two-fold change and FDR < 0.05)